EG15890A - Pyridoxine derivatives,process for preparing them and use in therapeutics - Google Patents

Pyridoxine derivatives,process for preparing them and use in therapeutics

Info

Publication number
EG15890A
EG15890A EG260/81A EG26081A EG15890A EG 15890 A EG15890 A EG 15890A EG 260/81 A EG260/81 A EG 260/81A EG 26081 A EG26081 A EG 26081A EG 15890 A EG15890 A EG 15890A
Authority
EG
Egypt
Prior art keywords
therapeutics
preparing
pyridoxine derivatives
pyridoxine
derivatives
Prior art date
Application number
EG260/81A
Other languages
English (en)
Inventor
Descahmps Marcel
Original Assignee
Labaz Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labaz Nv filed Critical Labaz Nv
Application granted granted Critical
Publication of EG15890A publication Critical patent/EG15890A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EG260/81A 1980-05-19 1981-05-12 Pyridoxine derivatives,process for preparing them and use in therapeutics EG15890A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8016516 1980-05-19

Publications (1)

Publication Number Publication Date
EG15890A true EG15890A (en) 1987-03-30

Family

ID=10513518

Family Applications (1)

Application Number Title Priority Date Filing Date
EG260/81A EG15890A (en) 1980-05-19 1981-05-12 Pyridoxine derivatives,process for preparing them and use in therapeutics

Country Status (32)

Country Link
US (1) US4374841A (el)
EP (1) EP0040591B1 (el)
JP (1) JPS5711966A (el)
AR (1) AR226356A1 (el)
AT (1) ATE3859T1 (el)
AU (1) AU542463B2 (el)
BG (1) BG35327A3 (el)
CA (1) CA1152080A (el)
CS (1) CS223842B2 (el)
DD (1) DD159071A5 (el)
DE (1) DE3160480D1 (el)
DK (1) DK217481A (el)
EG (1) EG15890A (el)
ES (1) ES502276A0 (el)
FI (1) FI811525L (el)
GR (1) GR82343B (el)
HU (1) HU183441B (el)
IE (1) IE51179B1 (el)
IL (1) IL62602A (el)
IN (1) IN151915B (el)
IS (1) IS1183B6 (el)
MA (1) MA19147A1 (el)
NO (1) NO811680L (el)
NZ (1) NZ196766A (el)
OA (1) OA06811A (el)
PL (1) PL129213B1 (el)
PT (1) PT72992B (el)
RO (1) RO81943A (el)
SU (1) SU1077566A3 (el)
YU (1) YU126281A (el)
ZA (1) ZA812448B (el)
ZW (1) ZW9681A1 (el)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663354A (en) * 1984-04-26 1987-05-05 Klinge Pharma Gmbh Use of etilefrin and etilefrin pivalate in the long term treatment of circulatory disorders not due to hypotonia
DE3519693A1 (de) * 1985-06-01 1987-01-02 Basf Ag Pyridin-derivate, ihre herstellung und verwendung
US6051587A (en) * 1998-04-16 2000-04-18 Medicure, Inc. Treatment of iatrogenic and age-related hypertension and pharmaceutical compositions useful therein
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
ATE306489T1 (de) 1999-03-08 2005-10-15 Medicure Inc Pyridoxal-analoge zur behandlung von störungen ausgelöst durch einen vitamin b6 mangel
AU5840200A (en) 1999-07-13 2001-01-30 Medicure Inc. Treatment of diabetes and related pathologies
WO2001013900A2 (en) 1999-08-24 2001-03-01 Medicure International Inc. Compositions for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
DE60110054T2 (de) 2000-02-29 2006-03-09 Medicure International Inc. Cardioprotektive phosphonate
US6586414B2 (en) 2000-03-28 2003-07-01 Medicure International Inc. Treatment of cerebrovascular disease
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
NZ523815A (en) 2000-07-07 2004-07-30 Medicure Int Inc Pyridoxine and pyridoxal analogues: cardiovascular therapeutics
US20040121988A1 (en) * 2001-03-28 2004-06-24 Medicure International Inc. Treatment of cerebrovascular disease
JP4048166B2 (ja) * 2002-11-18 2008-02-13 三井製糖株式会社 血糖値上昇抑制剤及び体脂肪蓄積抑制剤並びに食用材料
US20040186077A1 (en) * 2003-03-17 2004-09-23 Medicure International Inc. Novel heteroaryl phosphonates as cardioprotective agents
AU2004224566A1 (en) * 2003-03-27 2004-10-07 Medicure Inc. Compositions for treating angina
US20060019929A1 (en) * 2004-07-07 2006-01-26 Albert Friesen Combination therapies employing platelet aggregation drugs
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
WO2006050598A1 (en) * 2004-10-28 2006-05-18 Medicure International Inc. Dual antiplatelet/anticoagulant pyridoxine analogs
US20060094749A1 (en) * 2004-10-28 2006-05-04 Medicure International Inc. Substituted pyridoxines as anti-platelet agents
US7459468B2 (en) * 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
JP2009517411A (ja) * 2005-11-28 2009-04-30 メディキュア インターナショナル インコーポレーテッド 心血管及び関連病状の処置のための調剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115575A (en) * 1973-02-20 1978-09-19 Ciba-Geigy Corporation 2-(3-Amino-2-hydroxy-propoxy)-pyrazines
AR206801A1 (es) * 1973-02-20 1976-08-23 Ciba Geigy Ag Procedimiento para la elaboracion de derivados del 1-pirid loxi-2-hidroxi-3-amino-propano
GB1485919A (en) * 1975-08-12 1977-09-14 Grindstedvaerket As Pyridine derivatives
DE2711655A1 (de) * 1977-03-17 1978-09-21 Basf Ag Pyridinyl-aminoalkylaether
US4210653A (en) * 1978-06-27 1980-07-01 Merck & Co., Inc. Pyridyloxypropanolamines

Also Published As

Publication number Publication date
DK217481A (da) 1981-11-20
NZ196766A (en) 1984-02-03
CS223842B2 (en) 1983-11-25
US4374841A (en) 1983-02-22
PL231193A1 (el) 1982-07-05
IL62602A (en) 1984-06-29
HU183441B (en) 1984-05-28
ES8203845A1 (es) 1982-04-01
RO81943B (ro) 1983-05-30
RO81943A (ro) 1983-06-01
PT72992B (en) 1982-07-01
DD159071A5 (de) 1983-02-16
OA06811A (fr) 1982-12-31
AU7053581A (en) 1981-11-26
GR82343B (el) 1984-12-13
DE3160480D1 (en) 1983-07-28
PL129213B1 (en) 1984-04-30
AU542463B2 (en) 1985-02-21
MA19147A1 (fr) 1981-12-31
YU126281A (en) 1984-02-29
ZA812448B (en) 1982-04-28
SU1077566A3 (ru) 1984-02-29
IS1183B6 (is) 1985-05-13
IE811085L (en) 1981-11-19
IE51179B1 (en) 1986-10-29
ES502276A0 (es) 1982-04-01
EP0040591B1 (fr) 1983-06-22
FI811525L (fi) 1981-11-20
NO811680L (no) 1981-11-20
ZW9681A1 (en) 1982-01-20
IS2631A7 (is) 1981-11-11
IL62602A0 (en) 1981-06-29
JPS5711966A (en) 1982-01-21
CA1152080A (en) 1983-08-16
AR226356A1 (es) 1982-06-30
ATE3859T1 (de) 1983-07-15
EP0040591A1 (fr) 1981-11-25
BG35327A3 (en) 1984-03-15
PT72992A (en) 1981-06-01
IN151915B (el) 1983-09-03

Similar Documents

Publication Publication Date Title
EG15890A (en) Pyridoxine derivatives,process for preparing them and use in therapeutics
ZA817675B (en) New nor-tropane and granatane derivatives,the process for preparing the same and their application in therapeutics
ZA801081B (en) Polyol derivatives,processes for preparing the same and their uses in therapeutics
GB2042522B (en) Nor-tropane derivatives a process for preparing same and their application in therapeutics
EP0029912A3 (en) Mould-half, in particular laminating mould-half, and process for making it
ZA813567B (en) Novel n-aryl azolone derivatives,the process for preparing the same and their application in therapeutics
EG18150A (en) Process for preparing furo-(3,4-c)-pyridine derivatives
MY8600008A (en) Thieno-pyridine derivatives, their preparation process and their therapeutic use
GB2053196B (en) Derivatives of 5h-furanone-2 and of 3h-dihydrofuranone-2,the process for preparing the same and their application in therapeutics
DE2860858D1 (en) Indolacetoxyacetylaminoacid derivatives, process for their preparation and their use in drugs
HUT36445A (en) Process for preparing glyoxal, alkyl-glyoxals and acetals thereof
DE3162203D1 (en) Isoindoline derivatives, process for their preparation and their use
DE3463041D1 (en) Tributylphenolether-glycidyl-sulphonates, process for their preparation and their use
DE3477662D1 (en) 3-phenyl-4-cyanopyrrole derivatives, process for their preparation and their use as microbicides
DE2860981D1 (en) 4-hydroxy-2-benzimidazolinone derivatives, process for their preparation and their use in medicaments
ZA802673B (en) Novel derivatives of 5h-furanone-2 and of 3h-dihydrofuranone-2, the process for preparing the same and their application in therapeutics
ZA80160B (en) Novel nor-tropane derivatives,a process for preparing same and their application in therapeutics
DE3362189D1 (en) 14-amino-steroid derivatives, process for their preparation and their use in therapy
ZA821823B (en) 4-fluoro-3-phenoxy-benzyl 3-alken-1-yl-2,2-dimethyl-cyclopro-panecarboxylates, a process for their preparation and their use in pest-combating agents
ZA847640B (en) Cinnamoic compounds,process for preparing same and use in therapeutics
GB2075983B (en) Pyridoxine derivatives process for preparing them and use in therapeutics
DE3160419D1 (en) Organophosphates, process for preparing them and their use in pesticidal compositions
ZA805164B (en) Decahydroquinolinol derivatives, process for preparing them and their uses in therapeutics
SG44483G (en) New 16-methoxy-16-methyl prostagland in e1 derivatives,a process for preparing them and their use as gastroprotective agents
DE2960859D1 (en) Cephalexin-amide complex, process for its production and use in cephalexin-monohydrate production